Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

TWINNING ON DNA-BASED CANCER VACCINES

Objective

The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

CSA - Coordination and support action

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-TWINN-2015

See all projects funded under this call

Coordinator

RIGAS STRADINA UNIVERSITATE
Net EU contribution
€ 357 575,00
Total cost
€ 357 575,00

Participants (3)